Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2024 Earnings Call Transcript August 5, 2024
Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.66785 EPS, expectations were $-1.3.
Operator: Hello, and welcome to the Axsome Therapeutics Second Quarter 2024 Financial Results Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded. It’s now my pleasure to turn the call over to Darren Opland, Director of Corporate...
